Literature DB >> 15765806

Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts.

Lucette A Cysique1, Paul Maruff, Bruce J Brew.   

Abstract

The objective of this study was to assess the prevalence and pattern of neuropsychological impairment in cohorts of human immunodeficiency virus (HIV)-infected individuals across pre- and post-HAART (highly active antiretroviral therapy) eras. Two cohorts of HIV-infected individuals attending tertiary referral hospital outpatient clinics were studied. The cohorts represented two eras of antiretroviral medication: monotherapy (n = 51) and HAART (n = 90). Each was compared in nine neuropsychological domains in regard to the prevalence as well as pattern of neuropsychological impairment. Because the authors intended to characterize the prevalence and pattern of neuropsychological deficits in nondemented advanced HIV-infected individuals, patients with a current diagnosis of acquired immunodeficiency syndrome (AIDS) dementia complex were not included. The prevalence of impairment was not significantly different across pre-HAART and HAART eras using a standard criterion to define impairment: -2 SD in two neuropsychological measures (41.1%/38.8%). Prevalence of deficits was not significantly reduced in patients with undetectable plasma viral load. The pattern of neuropsychological impairment was different across pre-HAART and HAART eras, with an improvement in attention, verbal fluency, visuoconstruction deficits, but a deterioration in learning efficiency and complex attention. This change remained even in patients with an undetectable plasma viral load, although the severity was partially diminished. Neuropsychological deficits remain common in the HAART era, essentially uninfluenced by HAART. The finding that some neuropsychological functions are improving while other are deteriorating indicates that these deficits do not reflect "burnt out" damage but rather that there is an active intracerebral process occurring, the nature of which is still to be determined.

Entities:  

Mesh:

Year:  2004        PMID: 15765806     DOI: 10.1080/13550280490521078

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  29 in total

1.  HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy.

Authors:  Jutta K Neuenburg; Hans R Brodt; Brian G Herndier; Markus Bickel; Peter Bacchetti; Richard W Price; Robert M Grant; Wolfgang Schlote
Journal:  J Acquir Immune Defic Syndr       Date:  2002-10-01       Impact factor: 3.731

2.  Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy.

Authors:  Gregory J Dore; Ann McDonald; Yueming Li; John M Kaldor; Bruce J Brew
Journal:  AIDS       Date:  2003-07-04       Impact factor: 4.177

3.  Changes in neuropsychological performance of AIDS-related complex patients who progress to AIDS.

Authors:  N Dunbar; M Perdices; A Grunseit; D A Cooper
Journal:  AIDS       Date:  1992-07       Impact factor: 4.177

4.  Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid.

Authors:  P H Cunningham; D G Smith; C Satchell; D A Cooper; B Brew
Journal:  AIDS       Date:  2000-09-08       Impact factor: 4.177

Review 5.  What's wrong with Bonferroni adjustments.

Authors:  T V Perneger
Journal:  BMJ       Date:  1998-04-18

6.  Neuropsychological function in asymptomatic HIV-1 infection: methodological issues.

Authors:  A C Grunseit; M Perdices; N Dunbar; D A Cooper
Journal:  J Clin Exp Neuropsychol       Date:  1994-12       Impact factor: 2.475

7.  Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples.

Authors:  G Venturi; M Catucci; L Romano; P Corsi; F Leoncini; P E Valensin; M Zazzi
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

8.  Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death.

Authors:  N C Sacktor; H Bacellar; D R Hoover; T E Nance-Sproson; O A Selnes; E N Miller; G J Dal Pan; C Kleeberger; A Brown; A Saah; J C McArthur
Journal:  J Neurovirol       Date:  1996-12       Impact factor: 2.643

9.  Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group.

Authors:  R J Ellis; K Hsia; S A Spector; J A Nelson; R K Heaton; M R Wallace; I Abramson; J H Atkinson; I Grant; J A McCutchan
Journal:  Ann Neurol       Date:  1997-11       Impact factor: 10.422

10.  Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study.

Authors:  J C McArthur; D R Hoover; H Bacellar; E N Miller; B A Cohen; J T Becker; N M Graham; J H McArthur; O A Selnes; L P Jacobson
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

View more
  172 in total

Review 1.  Differentiating HIV-Associated Neurocognitive Disorders From Alzheimer's Disease: an Emerging Issue in Geriatric NeuroHIV.

Authors:  Benedetta Milanini; Victor Valcour
Journal:  Curr HIV/AIDS Rep       Date:  2017-08       Impact factor: 5.071

2.  Interruptions of antiretroviral therapy in human immunodeficiency virus infection: are they detrimental to neurocognitive functioning?

Authors:  Jose A Muñoz-Moreno; Carmina R Fumaz; Anna Prats; Maria J Ferrer; Eugènia Negredo; Núria Pérez-Alvarez; José Moltó; Guadalupe Gómez; Maite Garolera; Bonaventura Clotet
Journal:  J Neurovirol       Date:  2010-05       Impact factor: 2.643

3.  Neuropsychological evaluation and follow up in jcv- and non-jcv-related leukoencephalopathies in HIV infection.

Authors:  C Zucchella; E Sinforiani; E Tavazzi; S Del Bue; S Novati; R Maserati; M Ceroni; S Bastianello; L Minoli; P Ferrante; E Marchioni
Journal:  Neurol Sci       Date:  2011-06-01       Impact factor: 3.307

4.  Potential utility of resting-state magnetoencephalography as a biomarker of CNS abnormality in HIV disease.

Authors:  James T Becker; Melissa Fabrizio; Gustavo Sudre; Anna Haridis; Timothy Ambrose; Howard J Aizenstein; William Eddy; Oscar L Lopez; David A Wolk; Lauri Parkkonen; Anto Bagic
Journal:  J Neurosci Methods       Date:  2012-03-05       Impact factor: 2.390

5.  Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons.

Authors:  David J Moore; Miguel Arce; Suzanne Moseley; J Allen McCutchan; Jennifer Marquie-Beck; Donald R Franklin; Florin Vaida; Cristian L Achim; Justin McArthur; Susan Morgello; David M Simpson; Benjamin B Gelman; Ann C Collier; Christina M Marra; David B Clifford; Robert K Heaton; Igor Grant
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2011       Impact factor: 2.198

6.  Clinical contributors to cerebral white matter integrity in HIV-infected individuals.

Authors:  Assawin Gongvatana; Ronald A Cohen; Stephen Correia; Kathryn N Devlin; Jadrian Miles; Hakmook Kang; Hernando Ombao; Bradford Navia; David H Laidlaw; Karen T Tashima
Journal:  J Neurovirol       Date:  2011-10-01       Impact factor: 2.643

7.  Efavirenz pharmacokinetics in cerebrospinal fluid and plasma over a 24-hour dosing interval.

Authors:  Aylin Yilmaz; Victoria Watson; Laura Dickinson; David Back
Journal:  Antimicrob Agents Chemother       Date:  2012-06-11       Impact factor: 5.191

8.  Quantitation of parvalbumin+ neurons and human immunodeficiency virus type 1 (HIV-1) regulatory gene expression in the HIV-1 transgenic rat: effects of vitamin A deficiency and morphine.

Authors:  Shireen Sultana; Huifen Li; Adam Puche; Odell Jones; Joseph L Bryant; Walter Royal
Journal:  J Neurovirol       Date:  2010-02       Impact factor: 2.643

Review 9.  Editorial neuroAIDS review.

Authors:  Paul Shapshak; Pandjassarame Kangueane; Robert K Fujimura; Deborah Commins; Francesco Chiappelli; Elyse Singer; Andrew J Levine; Alireza Minagar; Francis J Novembre; Charurut Somboonwit; Avindra Nath; John T Sinnott
Journal:  AIDS       Date:  2011-01-14       Impact factor: 4.177

10.  Transcriptome analysis of HIV-infected peripheral blood monocytes: gene transcripts and networks associated with neurocognitive functioning.

Authors:  Andrew J Levine; Steve Horvath; Eric N Miller; Elyse J Singer; Paul Shapshak; Gayle C Baldwin; Otoniel Martínez-Maza; Mallory D Witt; Peter Langfelder
Journal:  J Neuroimmunol       Date:  2013-09-26       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.